ReviewRheumatic diseases clinics of North America2014
Gout: a review of nonmodifiable and modifiable risk factors.
Review in Rheumatic diseases clinics of North America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
48 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Gout disease-related years lived with disability in the North Africa and Middle East countries: a systematic analysis of the GBD study 1990-2019.Rheumatology international · 2025Pooled it
- Single-nucleotide polymorphisms link gout with health-related lifestyle factors in Korean cohorts.PloS one · 2023Pooled it
- Reporting quality of clinical practice guidelines regarding gout and hyperuricemia according to the RIGHT checklist: systematic review.Systematic reviews · 2021Pooled it
- Dietary Interventions for Gout and Effect on Cardiovascular Risk Factors: A Systematic Review.Nutrients · 2019Pooled it
- Association between SLC2A9 (GLUT9) gene polymorphisms and gout susceptibility: an updated meta-analysis.Rheumatology international · 2016Pooled it
- Glycaemic, uricaemic and blood pressure response to beverages with partial fructose replacement of sucrose.European journal of clinical nutrition · 2018Trial
- Clinical and inflammatory factors associated with prevalent gout in a Brazilian hospital population.Clinics (Sao Paulo, Brazil) · 2026Article
- URAT1 inhibition in hyperuricemia and gout: from transporter biology to clinical precision therapy.Frontiers in immunology · 2026Review
- Nutrient intake and diet quality in individuals with hyperuricemia: a matched population study.Frontiers in nutrition · 2026Article
- Burden of gout among different WHO regions, 1990-2019: estimates from the global burden of disease study.Scientific reports · 2024Article
- Association of non-high-density lipoprotein cholesterol-to-high-density lipoprotein cholesterol ratio (NHHR) with gout prevalence: a cross-sectional study.Frontiers in nutrition · 2024Article
- Timely Shaver Treatment Removes Chronic Tophaceous Mass Improve Surgical Outcomes.International journal of medical sciences · 2024Article
- The Evolving Landscape of Gout in the Female: A Narrative Review.Gout, urate, and crystal deposition disease · 2023Article
- Association between Asymptomatic Hyperuricemia with Adiposity Indices: A Cross-Sectional Study in a Spanish Population.Nutrients · 2023Article
- Association between Dietary Acid Load and Hyperuricemia in Chinese Adults: Analysis of the China Health and Nutrition Survey (2009).Nutrients · 2023Article
- Confirming Prior and Identifying Novel Correlates of Acute Calcium Pyrophosphate Crystal Arthritis.Arthritis care & research · 2023Article
- Epidemiology and risk factors associated with gout control among adult Asians: a real-world retrospective cohort study.Frontiers in medicine · 2023Article
- A randomized pilot trial assessing the reduction of gout episodes in hyperuricemic patients by oral administration ofFrontiers in microbiology · 2023Article
- Hyperuricemia is associated with secondary hyperparathyroidism in patients with chronic kidney disease.International urology and nephrology · 2022Article
- Comparison of Benzbromarone and Allopurinol on Primary Prevention of the First Gout Flare in Asymptomatic Hyperuricemia.Journal of personalized medicine · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Gout is a common inflammatory arthritis triggered by the crystallization of uric acid within the joints. Gout affects millions worldwide and has an increasing prevalence. Recent research has been carried out to better qualify and quantify the risk factors predisposing individuals to gout. These can largely be broken into nonmodifiable risk factors, such as gender, age, race, and genetics, and modifiable risk factors, such as diet and lifestyle. Increasing knowledge of factors predisposing certain individuals to gout could potentially lead to improved preventive practices. This review summarizes the nonmodifiable and modifiable risk factors associated with development of gout.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.